Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Pancreatic Neoplasms 8Multiple Myeloma 6Neoplasms, Plasma Cell 4Myelodysplastic Syndromes 4Leukemia, Myeloid, Acute 4Prostatic Neoplasms 3Leukemia, Myelomonocytic, Chronic 3Sarcoma 2Myeloproliferative Disorders 2Lymphoma 2Lung Neoplasms 2Inflammation 2Frailty 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Adenocarcinoma 2Ventilator-Induced Lung Injury 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Stomatitis 1Stomach Neoplasms 1Rectal Neoplasms 1Primary Myelofibrosis 1Postoperative Complications 1Pancreatic Diseases 1Ovarian Neoplasms 1Neoplasms by Site 1Neoplasms 1Myelodysplastic-Myeloproliferative Diseases 1Mucositis 1

Interventions

Cisplatin 68Paclitaxel 32Radiotherapy 31Carboplatin 23Bevacizumab 21pembrolizumab 20Brachytherapy 18atezolizumab 11camrelizumab 10Nivolumab 10Gemcitabine 10Drug Therapy 9tislelizumab 8Topotecan 8Taxes 8Chemoradiotherapy 8Radiation 7Docetaxel 7Albumin-Bound Paclitaxel 7zimberelimab 6toripalimab 6nimotuzumab 6Magnetic Resonance Spectroscopy 6Cetuximab 6lenvatinib 5durvalumab 5dostarlimab 5Platinum 5Papillomavirus Vaccines 5Injections 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Uterine Cervical Neoplasms × Ascorbic Acid × Clear all
NCT00284427 2016-02-10

Safety of Antioxidants During GYN Cancer Care

University of Kansas Medical Center

Phase 2 Completed
25 enrolled
Gynecologic

Uterine Cervical Neoplasms, Ovarian Neoplasms, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡